Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Medtronic
MDT
|
$580M |
| 2 |
Citigroup
C
|
$486M |
| 3 |
Cimpress
CMPR
|
$398M |
| 4 |
Broadcom
AVGO
|
$367M |
| 5 |
Apple
AAPL
|
$285M |
Top Sells
| 1 |
RAI
Reynolds American Inc
RAI
|
$348M |
| 2 |
Microsoft
MSFT
|
$337M |
| 3 |
IQVIA
IQV
|
$249M |
| 4 |
Costco
COST
|
$202M |
| 5 |
AbbVie
ABBV
|
$177M |
Sector Composition
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.75% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Okta
OKTA
$16.1B
| $10.8M | 0.01% |
383,840
-7,220
| -2% | -$204K |
|
|
CXO
852
DELISTED
CONCHO RESOURCES INC.
CXO
| $10.8M | 0.01% |
82,086
-32,302
| -28% | -$4.26M |
|
853
Huazhu Hotels Group
HTHT
$11.6B
| $10.7M | 0.01% |
361,132
-180,800
| -33% | -$5.37M |
|
854
Erie Indemnity
ERIE
$17.6B
| $10.7M | 0.01% |
88,510
+1,100
| +1% | +$133K |
|
855
Supernus Pharmaceuticals
SUPN
$2.6B
| $10.6M | 0.01% |
+266,146
| New | +$10.6M |
|
|
VVC
856
DELISTED
Vectren Corporation
VVC
| $10.6M | 0.01% |
160,410
+6,400
| +4% | +$421K |
|
857
Emerson Electric
EMR
$75B
| $10.5M | 0.01% |
167,422
+54,592
| +48% | +$3.43M |
|
858
LivaNova
LIVN
$3.16B
| $10.5M | 0.01% |
149,984
-59,151
| -28% | -$4.14M |
|
859
Hologic
HOLX
$14.7B
| $10.5M | 0.01% |
285,035
+38,283
| +16% | +$1.4M |
|
860
NiSource
NI
$18.9B
| $10.3M | 0.01% |
401,087
+91,675
| +30% | +$2.35M |
|
861
Royal Caribbean
RCL
$95.4B
| $10.2M | 0.01% |
86,370
+24,278
| +39% | +$2.88M |
|
862
HEICO
HEI
$44.7B
| $10.2M | 0.01% |
221,811
-34,685
| -14% | -$1.59M |
|
863
Kinder Morgan
KMI
$58.6B
| $10.1M | 0.01% |
528,515
-9,400
| -2% | -$180K |
|
864
Sonida Senior Living
SNDA
$484M
| $10.1M | 0.01% |
53,549
-15,501
| -22% | -$2.92M |
|
865
Novo Nordisk
NVO
$243B
| $10.1M | 0.01% |
418,468
-9,112
| -2% | -$219K |
|
866
International Flavors & Fragrances
IFF
$16.9B
| $10M | 0.01% |
70,190
-33,431
| -32% | -$4.78M |
|
|
ESRX
867
DELISTED
Express Scripts Holding Company
ESRX
| $9.92M | 0.01% |
156,653
+44,842
| +40% | +$2.84M |
|
|
SGEN
868
DELISTED
Seagen Inc. Common Stock
SGEN
| $9.84M | 0.01% |
180,873
-523,800
| -74% | -$28.5M |
|
|
LTC
869
LTC Properties
LTC
$1.68B
| $9.8M | 0.01% |
208,565
+33,964
| +19% | +$1.6M |
|
|
BEST
870
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $9.7M | 0.01% |
+40,531
| New | +$9.7M |
|
871
Ollie's Bargain Outlet
OLLI
$8.16B
| $9.67M | 0.01% |
+208,321
| New | +$9.67M |
|
872
D.R. Horton
DHI
$54.8B
| $9.64M | 0.01% |
241,320
+146,351
| +154% | +$5.84M |
|
|
COR
873
DELISTED
Coresite Realty Corporation
COR
| $9.57M | 0.01% |
+85,535
| New | +$9.57M |
|
874
Skyworks Solutions
SWKS
$11.1B
| $9.55M | 0.01% |
93,691
-138,518
| -60% | -$14.1M |
|
875
McKesson
MCK
$85.9B
| $9.45M | 0.01% |
61,515
-85,176
| -58% | -$13.1M |
|